Why is collaboration between regulators and the scientific community so essential to spur innovation in Alzheimer’s? In this episode, current and former regulatory officials take a page from the COVID-19 playbook, highlighting the vital need for transparent communication and cooperation across all stakeholders. The key: work together to advance incremental innovations that can eventually transform a devastating disease into a manageable condition.

Podden och tillhörande omslagsbild på den här sidan tillhör The Global CEO Initiative on Alzheimer's Disease. Innehållet i podden är skapat av The Global CEO Initiative on Alzheimer's Disease och inte av, eller tillsammans med, Poddtoppen.